Skip to main content

Sleep Disorders in Multiple Sclerosis. Review

Current Neurology and Neuroscience Reports volume 15, Article number: 21 (2015) Cite this article

Abstract

Sleep disorders are common in patients with multiple sclerosis (MS) and play a crucial role in health and quality of life; however, they are often overlooked. The most important sleep disorders in this context are as follows: insomnia, restless legs syndrome, periodic limb movement disorders, and sleep-related breathing disorders (SRBD). It is unclear if MS-related processes (lesions, brain atrophy) can cause symptomatic forms of sleep apnea. MS-related narcolepsy-like symptoms are described in the literature and, in some cases, have resolved with methylprednisolone pulse therapy. Similarly, REM sleep behavior disorder (RBD) is very rare in MS, but it can be an initial sign of MS where cortisone therapy may be helpful and can be taken into account in this specific context. Independent diagnosis and treatment is required for all of the abovementioned conditions. Treating physicians and neurologists should be aware of these comorbidities and initiate specific therapy. Highly fatigued or sleepy MS patients should have polysomnography in order not to overlook these diagnoses.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Compston A, Coles A. Multiple sclerosis. Lancet. 2002;359:1221–31.

    Article  PubMed  Google Scholar 

  2. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998;338:278–85.

    Article  CAS  PubMed  Google Scholar 

  3. Farez MF, Balbuena Aguirre ME, Varela F, Köhler AA, Correale J. Autoimmune disease prevalence in a multiple sclerosis cohort in Argentina. Mult Scler Int. 2014;828162. doi: 10.1155/2014/828162.

  4. Chitnis T, Glanz B, Jaffin S, Healy B. Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Mult Scler. 2009;15(5):627–31. doi:10.1177/1352458508101933.

    Article  CAS  PubMed  Google Scholar 

  5. World Health Organization. Atlas multiple sclerosis resources in the world 2008. Geneva: WHO Press; 2008.

    Google Scholar 

  6. Evans C, Beland SG, Kulaga S, Wolfson C, Kingwell E, Marriott J, et al. Incidence and prevalence of multiple sclerosis in the Americas: a systematic review. Neuroepidemiology. 2013;40(3):195–210. doi:10.1159/000342779.

    Article  PubMed  Google Scholar 

  7. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230–5.

    Article  CAS  PubMed  Google Scholar 

  8. Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med. 2004;164(2):196–202.

    Article  PubMed  Google Scholar 

  9. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6:97–111.

    Article  PubMed  Google Scholar 

  10. Manconi M, Ferini-Strambi L, Filippi M, Bonanni E, Iudice A, Murri L, et al. Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS Study. Sleep. 2008;31:944–52.

    PubMed Central  PubMed  Google Scholar 

  11. Nishino S, Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev. 2005;9(4):269–310.

    Article  PubMed  Google Scholar 

  12. Veauthier C, Radbruch H, Gaede G, Pfueller CF, Dörr J, Bellmann-Strobl J, et al. Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study. Mult Scler. 2011;17(5):613–22. doi:10.1177/1352458510393772.

    Article  CAS  PubMed  Google Scholar 

  13. American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd ed: Diagnostic and Coding Manual. Darien: American Academy of Sleep Medicine; 2014. The third revision (ICSD-3) is the authoritative clinical text for the diagnosis and treatment of sleep disorders and an essential reference for all clinicians treating patients with sleep disorders. The third revision shows significant content changes, including new nomenclature, classifications and diagnoses.

  14. Borel JC, Borel AL, Monneret D, Tamisier R, Levy P, Pepin JL. Obesity hypoventilation syndrome: from sleep-disordered breathing to systemic comorbidities and the need to offer combined treatment strategies. Respirology. 2012;17(4):601–10. doi:10.1111/j.1440-1843.2011.02106.x.

    Article  PubMed  Google Scholar 

  15. Khan MT, Franco RA. Complex sleep apnea syndrome. Sleep Disorders. 2014;2014:798487. doi:10.1155/2014/798487.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Guilleminault C, Lopes MC, Hagen CC, da Rosa A. The cyclic alternating pattern demonstrates increased sleep instability and correlates with fatigue and sleepiness in adults with upper airway resistance syndrome. Sleep. 2007;30(5):641–7.

    PubMed  Google Scholar 

  17. Guilleminault C, Stoohs R, Clerk A, Simmons J, Labanowski M. From obstructive sleep apnea syndrome to upper airway resistance syndrome: consistency of daytime sleepiness. Sleep. 1992;15(6 Suppl):S13–6.

    CAS  PubMed  Google Scholar 

  18. Veauthier C, Paul F. Sleep disorders in multiple sclerosis and their relationship to fatigue. Sleep Med. 2014;15(1):5–14. doi:10.1016/j.sleep.2013.08.791. This recently published review highlights the relationship between MS related fatigue and sleep disorders and summarizes in particular the studies investigating insomnia in MS patients.

    Article  PubMed  Google Scholar 

  19. Kaminska M, Kimoff RJ, Benedetti A, Robinson A, Bar-Or A, Lapierre Y, et al. Obstructive sleep apnea is associated with fatigue in multiple sclerosis. Mult Scler. 2012;18(8):1159–69. doi:10.1177/1352458511432328.

    Article  CAS  PubMed  Google Scholar 

  20. Iber C, Ancoli-Israel S, Chesson Jr AL. American Academy of Sleep Medicine. The AASM Manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Westchester: American Academy of Sleep Medicine; 2007.

    Google Scholar 

  21. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep. 1999;22:667–89.

    Google Scholar 

  22. Côté I, Trojan DA, Kaminska M, Cardoso M, Benedetti A, Weiss D, et al. Impact of sleep disorder treatment on fatigue in multiple sclerosis. Mult Scler. 2013;19(4):480–9. doi:10.1177/1352458512455958.

    Article  PubMed  Google Scholar 

  23. Veauthier C, Gaede G, Radbruch H, Gottschalk S, Wernecke KD, Paul F. Treatment of sleep disorders may improve fatigue in multiple sclerosis. Clin Neurol Neurosurg. 2013;115(9):1826–30. doi:10.1016/j.clineuro.2013.05.018.

    Article  PubMed  Google Scholar 

  24. Kallweit U, Baumann CR, Harzheim M, Hidalgo H, Pöhlau D, Bassetti CL, et al. Fatigue and sleep-disordered breathing in multiple sclerosis: a clinically relevant association? Mult Scler Int. 2013;2013:286581. doi:10.1155/2013/286581.

    PubMed Central  PubMed  Google Scholar 

  25. Braley TJ, Chervin RD, Segal BM. Fatigue, tiredness, lack of energy, and sleepiness in multiple sclerosis patients referred for clinical polysomnography. Mult Scler Int. 2012:673936. doi: 10.1155/2012/673936.

  26. Chen JH, Liu XQ, Sun HY, Huang Y. Sleep disorders in multiple sclerosis in China: clinical, polysomnography study, and review of the literature. J Clin Neurophysiol. 2014;31(4):375–81. doi:10.1097/WNP.0000000000000067.

    Article  CAS  PubMed  Google Scholar 

  27. Veauthier C, Paul F. Fatigue in multiple sclerosis: which patient should be referred to a sleep specialist? Mult Scler. 2012;18(2):248–9. doi:10.1177/1352458511411229. For clinicians it is difficult to decide which patient should be admitted to a sleep laboratory for polysomnographic analyzes. The authors analyzed retrospectively their data of the first cross-sectional polysomnographic trial in order to find out a screening instrument.

    Article  PubMed  Google Scholar 

  28. Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Washington, DC: Paralyzed Veterans of America; 1998.

    Google Scholar 

  29. Flachenecker P, Kümpfel T, Kallmann B, Gottschalk M, Grauer O, Rieckmann P, et al. Fatigue in multiple sclerosis: a comparison of different rating scales. Mult Scler. 2002;8:523–6.

    Article  CAS  PubMed  Google Scholar 

  30. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.

    Article  CAS  PubMed  Google Scholar 

  31. Braley TJ, Segal BM, Chervin RD. Sleep-disordered breathing in multiple sclerosis. Neurology. 2012;79(9):929–36. doi:10.1212/WNL.0b013e318266fa9d. This is the first study investigating the possible pathomechanism of unexplored and presumed “symptomatic” SRBD in MS.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service/Brain Research Institute, UCLA; 1968.

    Google Scholar 

  33. Lichstein KL, Means MK, Noe SL, Aguillard RN. Fatigue and sleep disorders. Behav Res Ther. 1997;35:733–40.

    Article  CAS  PubMed  Google Scholar 

  34. Bardwell WA, Moore P, Ancoli-Israel S, Dimsdale JE. Fatigue in obstructive sleep apnea: driven by depressive symptoms instead of apnea severity? Am J Psychiatry. 2003;160:350–5.

    Article  PubMed  Google Scholar 

  35. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: American Psychiatric Association; 1994.

    Google Scholar 

  36. World Health Organization. The ICD-10 classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.

    Google Scholar 

  37. Brass SD, Li CS, Auerbach S. The underdiagnosis of sleep disorders in patients with multiple sclerosis. J Clin Sleep Med. 2014;10(9):1025–31. doi:10.5664/jcsm.4044.

    PubMed Central  PubMed  Google Scholar 

  38. Leonavicius R, Adomaitiene V. Features of sleep disturbances in multiple sclerosis patients. Psychiatr Danub. 2014;26(3):249–55.

    PubMed  Google Scholar 

  39. Hays R, Stewart A. Sleep measures. In: Stewart A, Ware J, editors. Measuring functioning and well-being: the medical outcomes study approach. Durham: Duke University Press; 1992. p. 235–9.

    Google Scholar 

  40. Tachibana N, Howard RS, Hirsch NP, et al. Sleep problems in multiple sclerosis. Eur Neurol. 1994;34:320–3.

    Article  CAS  PubMed  Google Scholar 

  41. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487–504.

    PubMed Central  PubMed  Google Scholar 

  42. Dauvilliers Y, Winkelmann J. Restless legs syndrome: update on pathogenesis. Curr Opin Pulm Med. 2013;19(6):594–600.

    Article  CAS  PubMed  Google Scholar 

  43. Winkelmann J, Schormair B, Lichtner P, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet. 2007;39(8):1000–6.

    Article  CAS  PubMed  Google Scholar 

  44. Winkelman JW. Periodic limb movements in sleep―endophenotype for restless legs syndrome? N Engl J Med. 2007;357(7):703–5.

  45. Aurora RN, Kristo DA, Bista SR, et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults-an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep. 2012;35:1039–62. This study summarizes recently performed treatment studies in the field of periodic limb movement disorder (PLMD) and restless legs syndrome (RLS) and can be considered as the actual guideline of the treatment of these two disorders.

    PubMed Central  PubMed  Google Scholar 

  46. Ondo WG. Restless legs syndrome: pathophysiology and treatment. Curr Treat Options Neurol. 2014;16(11):317. doi:10.1007/s11940-014-0317-2.

    Article  PubMed  Google Scholar 

  47. Cho YW, Allen RP, Earley CJ. Lower molecular weight intravenous iron dextran for restless legs syndrome. Sleep Med. 2013;14(3):274–7. doi:10.1016/j.sleep.2012.11.001. Iron therapy is underestimated in the treatment of RLS and it is important to point out, that this therapy can improve RLS and should not be forgotten.

    Article  PubMed  Google Scholar 

  48. Garcia-Borreguero D, Patrick J, DuBrava S, Becker PM, Lankford A, Chen C, et al. Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome. Sleep. 2014;37(4):635–43. doi:10.5665/sleep.3558.

    PubMed Central  PubMed  Google Scholar 

  49. Akintomide GS, Rickards H. Narcolepsy: a review. Neuropsychiatr Dis Treat. 2011;7:507–18. doi:10.2147/NDT.S23624.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  50. Sansa G, Iranzo A, Santamaria J. Obstructive sleep apnea in narcolepsy. Sleep Med. 2010;11(1):93–5.

    Article  PubMed  Google Scholar 

  51. Knudsen S, Gammeltoft S, Jennum PJ. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency. Brain. 2010;133(Pt 2):568–79.

    Article  PubMed  Google Scholar 

  52. Schenck CH, Mahowald MW. Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder. Ann Neurol. 1992;32(1):3–10.

    Article  CAS  PubMed  Google Scholar 

  53. Schenck CH, Hurwitz TD, Bundlie SR, Mahowald MW. Sleep-related eating disorders: polysomnographic correlates of a heterogeneous syndrome distinct from daytime eating disorders. Sleep. 1991;14(5):419–31.

    CAS  PubMed  Google Scholar 

  54. Longstreth Jr WT, Koepsell TD, Ton TG, Hendrickson AF, van Belle G. The epidemiology of narcolepsy. Sleep. 2007;30(1):13–26.

    PubMed  Google Scholar 

  55. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92(4):573–85.

    Article  CAS  PubMed  Google Scholar 

  56. De Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, et al. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A. 1998;95(1):322–7.

    Article  PubMed Central  PubMed  Google Scholar 

  57. Preedy VR, Watson RR, Martin CR. Handbook of behavior, food and nutrition. New York: Springer; 2011.

    Book  Google Scholar 

  58. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Compt Neurol. 2001;435(1):6–25.

    Article  CAS  Google Scholar 

  59. Berg O, Hanley J. Narcolepsy in two cases of multiple sclerosis. Acta Neurol Scand. 1963;39:252–6.

    Article  CAS  PubMed  Google Scholar 

  60. Ekbom K. Familial multiple sclerosis associated with narcolepsy. Arch Neurol. 1966;15(4):337–44.

    Article  CAS  PubMed  Google Scholar 

  61. Schrader H, Gotlibsen OB, Skomedal GN. Multiple sclerosis and narcolepsy/cataplexy in a monozygotic twin. Neurology. 1980;30(1):105–8.

    Article  CAS  PubMed  Google Scholar 

  62. Younger DS, Pedley TA, Thorpy MJ. Multiple sclerosis and narcolepsy: possible similar genetic susceptibility. Neurology. 1991;41(3):447–8.

    Article  CAS  PubMed  Google Scholar 

  63. Wang CY, Kawashima H, Takami T, Yamada N, Miyajima T, Ogihara M, et al. [A case of multiple sclerosis with initial symptoms of narcolepsy]. [Article in Japanese]. No To Hattatsu. 1998;30(4):300–6.

    CAS  PubMed  Google Scholar 

  64. Iseki K, Mezaki T, Oka Y, Terada K, Tomimoto H, Miki Y, et al. Hypersomnia in MS. Neurology. 2002;59(12):2006–7.

    Article  CAS  PubMed  Google Scholar 

  65. Oka Y, Kanbayashi T, Mezaki T, Iseki K, Matsubayashi J, Murakami G, et al. Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis. J Neurol. 2004;251(7):885–6.

    Article  PubMed  Google Scholar 

  66. Kato T, Kanbayashi T, Yamamoto K, Nakano T, Shimizu T, Hashimoto T, et al. Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions. Intern Med. 2003;42(8):743–5.

    Article  PubMed  Google Scholar 

  67. Vetrugno R, Stecchi S, Plazzi G, Lodi R, D'Angelo R, Alessandria M, et al. Narcolepsy-like syndrome in multiple sclerosis. Sleep Med. 2009;10(3):389–91. doi:10.1016/j.sleep.2008.03.009.

    Article  PubMed  Google Scholar 

  68. Vrethem M, Malmgren K, Lindh J. A patient with both narcolepsy and multiple sclerosis in association with Pandemrix vaccination. J Neurol Sci. 2012;321(1–2):89–91.

    Article  PubMed  Google Scholar 

  69. Peraita-Adrados R, Lammers GJ, De Andrés C, Santamaría J, Vicario JL, Tafti M. A patient with narcolepsy with cataplexy and multiple sclerosis: two different diseases that may share pathophysiologic mechanisms? Sleep Med. 2013;14(7):695–6. doi:10.1016/j.sleep.2013.03.015. Epub 2013 May 18.

    Article  PubMed  Google Scholar 

  70. Martínez-Orozco FJ, Vicario JL, Villalibre-Valderrey I, De Andrés C, Fernández-Arquero M, Peraita-Adrados R. Narcolepsy with cataplexy and comorbid immunopathological diseases. J Sleep Res. 2014;23(4):414–9. doi:10.1111/jsr.12143. Epub 2014 Mar 20.

    Article  PubMed  Google Scholar 

  71. Jacobsohn E. Ein Fall von Narkolepsie. Klin Wochenschrift. 1926;2:2188.

    Google Scholar 

  72. Heyck H, Hess R. Some results of clinical studies on narcolepsy. Schweiz Arch Neurol Psychiatr. 1955;75(1–2):401–2.

    CAS  PubMed  Google Scholar 

  73. Dauvilliers. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry. 2003;74(12):1667–73.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  74. Shiina T, Hosomichi K, Inoko H, Kulski JK. The HLA genomic loci map: expression, interaction, diversity and disease. J Hum Genet. 2009;54(1):15–39. doi:10.1038/jhg.2008.5.

    Article  CAS  PubMed  Google Scholar 

  75. Ringquist S, Bellone G, Lu Y, Roeder K, Trucco M. Clustering and alignment of polymorphic sequences for HLA-DRB1 genotyping. Plos One. 2013;8(3):e59835. doi:10.1371/journal.pone.0059835.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  76. Bontadini A. HLA techniques: typing and antibody detection in the laboratory of immunogenetics. Methods. 2012;56(4):471–6.

    Article  CAS  PubMed  Google Scholar 

  77. Rubio JP, Bahlo M, Stankovich J, Burfoot RK, Johnson LJ, Huxtable S, et al. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients. Immunogenetics. 2007;59(3):177–86.

    Article  CAS  PubMed  Google Scholar 

  78. Watson NF, Ton TG, Koepsell TD, Gersuk VH, Longstreth Jr WT. Does narcolepsy symptom severity vary according to HLA-DQB1*0602 allele status? Sleep. 2010;33(1):29–35.

    PubMed Central  PubMed  Google Scholar 

  79. van der Heide A, Verduijn W, Haasnoot GW, Drabbels JJ, Lammers GJ, Claas FH. HLA dosage effect in narcolepsy with cataplexy. Immunogenetics. 2014.

  80. Han F, Lin L, Schormair B, Pizza F, Plazzi G, Ollila HM, et al. HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency. Sleep. 2014;37(10):1601–8. doi:10.5665/sleep.4066. There are only few HLA DQB1*06:02 negative patients suffering from narcolepsy with cataplexy and hypocretin deficiency. This recently published article suggests a possible secondary association in these cases with HLA-DP.

    PubMed Central  PubMed  Google Scholar 

  81. Poirier G, Montplaisir J, Dumont M, Duquette P, Décary F, Pleines J, et al. Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology. 1987;37(4):693–5.

    Article  CAS  PubMed  Google Scholar 

  82. Kaynak H, Altintas A, Kaynak D, Uyanik O, Saip S, Ağaoğlu J, et al. Fatigue and sleep disturbance in multiple sclerosis. Eur J Neurol. 2006;13:1333–9.

    Article  CAS  PubMed  Google Scholar 

  83. Neau JP, Paquereau J, Auche V, Mathis S, Godeneche G, Ciron J, et al. Sleep disorders and multiple sclerosis: a clinical and polysomnography study. Eur Neurol. 2012;68(1):8–15. doi:10.1159/000335076.

    Article  PubMed  Google Scholar 

  84. Huitinga I, Erkut Z, van Beurden D, Swaab DF. The hypothalamo-pituitary-adrenal axis in multiple sclerosis. Ann NY Acad Sci. 2003;992:118–28.

    Article  CAS  PubMed  Google Scholar 

  85. Plazzi G, Montagna P. Remitting REM sleep behaviour disorder as the initial sign of multiple sclerosis. Sleep Med. 2002;3:437–9.

    Article  PubMed  Google Scholar 

  86. Tippmann-Peikert M, Boeve BF, Keegan BM. REM sleep behavior disorder initiated by acute brainstem multiple sclerosis. Neurology. 2006;66(8):1277–9.

    Article  PubMed  Google Scholar 

  87. Gómez-Choco MJ, Iranzo A, Blanco Y, et al. Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis. Mult Scler. 2007;13:805–8.

    Article  PubMed  Google Scholar 

  88. Iranzo A, Aparicio J. A lesson from anatomy: focal brain lesions causing REM sleep behavior disorder. Sleep Med. 2009;1:9–12. doi:10.1016/j.sleep.2008.03.005.

    Article  Google Scholar 

Download references

Acknowledgments

The author thanks Dr. Gosia Sullivan for reviewing the manuscript.

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

Christian Veauthier declares no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Interdisciplinary Center of Sleep Medicine, Charité University Medicine Berlin, Charitéplatz 1, 10117, Berlin, Germany

    Christian Veauthier

Authors
  1. Christian Veauthier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian Veauthier.

Additional information

This article is part of the Topical Collection on Sleep

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Veauthier, C. Sleep Disorders in Multiple Sclerosis. Review. Curr Neurol Neurosci Rep 15, 21 (2015). https://doi.org/10.1007/s11910-015-0546-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11910-015-0546-0

Keywords

  • Restless legs syndrome
  • Periodic limb movement disorder
  • Nocturia
  • Insomnia
  • Sleep apnea
  • Polysomnography